Egetis Therapeutics AB (publ) (STO:EGTX)
11.12
0.00 (0.00%)
Nov 20, 2026, 5:29 PM CET
Egetis Therapeutics AB Revenue
Egetis Therapeutics AB had revenue of 21.50M SEK in the quarter ending September 30, 2026, with 23.56% growth. This brings the company's total for the last twelve months to 70.10M, up 26.53% year-over-year. In the year 2025, Egetis Therapeutics AB had annual revenue of 62.40M with 35.36% growth. That makes Egetis Therapeutics AB the 38,933rd largest company in the world by revenue and 539th in Sweden.
Revenue (ttm)
70.10M
Revenue Growth
+26.53%
P/S Ratio
73.86
Revenue / Employee
1.15M
Employees
61
Market Cap
5.17B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Egetis Therapeutics AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.40M | 16.30M | 35.36% |
| Dec 31, 2024 | 46.10M | -11.50M | -19.97% |
| Dec 31, 2023 | 57.60M | 35.00M | 154.87% |
| Dec 31, 2022 | 22.60M | -15.60M | -40.84% |
| Dec 31, 2021 | 38.20M | -2.46M | -6.05% |
| Dec 31, 2020 | 40.66M | -41.90M | -50.75% |
| Dec 31, 2019 | 82.56M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioArctic AB | 1.00B |
| Saniona AB | 424.56M |
| Hansa Biopharma AB | 301.64M |
| Genovis AB (publ.) | 145.23M |
| Oncopeptides AB | 103.50M |
| Medivir AB | 8.51M |
| Vicore Pharma Holding AB | 3.83M |
| Flerie AB | 2.60M |
Egetis Therapeutics AB News
- 16 days ago - Egetis downgraded to Neutral from Overweight at Cantor Fitzgerald - TheFly
- 17 days ago - Egetis Therapeutics AB Quarterly report: Q3 2026 - Filings
- 7 weeks ago - Egetis Therapeutics AB Transcript: FDA announcement - Transcripts
- 7 weeks ago - Egetis Therapeutics AB Press release: FDA announcement - Filings
- 7 weeks ago - Egetis Therapeutics AB Slides: FDA announcement - Filings
- 2 months ago - Egetis Therapeutics AB Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Egetis Therapeutics AB Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 2 months ago - Egetis Therapeutics AB Slides: Corporate presentation - Filings